Road to AgSuccess?

Rosetta Green, an Israeli biotech company focused on uncovering genes that can be used to improve agricultural and biofuel crops, has been bought by Monsanto fro $35 million, reports Bioentrepreneur's Trade Secrets blog. Rosetta Green was a spinoff from Rosetta Genomics.

This, writes Bernard Dichek at Trade Secrets, could be the beginning of a trend.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PNAS

Still Concerns

This Week in PLOS

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.